Upper Limb Movement
The ARCEX System is now
available for purchase
External Platform
External Platform
-
The first system approved for non-invasive spinal cord stimulation for people with spinal cord injury (SCI).
The ARCEX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).
Submit form
In 2024, the ARCEX System was granted FDA clearance to market in the United States. Submit the “Contact Us” form to learn more.
Discover how ARCEX Works
ARCEX is designed to help people with spinal cord injury improve independence.
The system is comprised of a Stimulator that delivers electrical pulses to the cervical spinal cord via Electrodes placed on the skin at the back of the neck.
ARCEX can be used in the clinic to enable personalized functional rehabilitation.
Discover how ARCEX Works
ARCEX is designed to help people with spinal cord injury improve independence.
The system is comprised of a Stimulator that delivers electrical pulses to the cervical spinal cord via Electrodes placed on the skin at the back of the neck.
ARCEX can be used in the clinic to enable personalized functional rehabilitation.
“When we talk about 10% more function, we think about how important that is in terms of being able to live a life. That little bit more independence allows you to do so much more.”
Jessie Owen
Note: Patient testimonials reflect individual experiences and outcomes, which may vary. Please review the full product label and clinical study data.
Please complete this form to
contact us or receive updates
Read our Publications
Read the Evidence
The results from our Up-LIFT pivotal trial were published in Nature Medicine, one of the world’s preeminent scientific journals.
The Up-LIFT study evaluated the safety and effectiveness of non-invasive electrical spinal cord stimulation (ARCEX Therapy) to improve hand sensation and strength in people with chronic incomplete tetraplegia. The clinical study enrolled 65 people at 14 leading SCI centers in the US, Europe, and Canada.
Highlights* include:
-Primary safety and effectiveness endpoints met.
-90% of participants improved strength or function of their upper limbs.
-Upper extremity sensory scores improved significantly with device use.
-87% of participants reported improvement in quality of life.
-Improvement was demonstrated in participants up to 34 years post-injury.
Find the answers to
Frequently Asked Questions
The ONWARD® Medical ARCEX® System is cleared for use only in the United States. The ARCEX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.
*Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024.